Toronto: Acutely ill premature babies who received fresher blood fare no better than those who did not, according to a clinical trial that challenges the widespread notion that fresh blood is better."Before now, most of the literature on the subject suggested that fresh red blood cells are better," says Dean Fergusson, head, Clinical Epidemiology Programme at the Ottawa Hospital Research Institute, who led the study."However, the effect of fresher blood on clinical outcomes had never been examined using a randomised clinical trial in human patients, which is considered the gold standard in medical science, Fergusson, also an associate professor at the University of Ottawa, was quoted as saying by the Journal of the American Medical Association."Now it has, and we found the standards currently in place are no different for this highly vulnerable population of pre-term infants than a policy and system that would favour fresh blood," he added, according to an Ottawa statement.
UN posting gives Devyani temporary immunity: US
Petrol, Diesel and milk prices hiked in Mumbai
`Dhoom 3` audience verdict
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi